Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Turnstone Biologics Corp. Common Stock, par value $0.001 per share (TSBX).
- Disclosed ownership: 0%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 0% ownership in Turnstone Biologics Corp. Common Stock, par value $0.001 per share (TSBX) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 0% | 0 | 0 | 0 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 0% | 0 | 0 | 0 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Biotech Private Investments, LLC | 0% | 0 | 0 | 0 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| Differentiated Ventures Investments, LLC | 0% | 0 | 0 | 0 | /s/ Vincent Tortorella | Vincent Tortorella, Authorized Person | |
| 72 Investment Holdings, LLC | 0% | 0 | 0 | 0 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 0% | 0 | 0 | 0 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |